Close Menu

NEW YORK (GenomeWeb) – Invitae reported after the close of the market Monday that its first quarter revenues climbed 158 percent year over year, falling short of the consensus Wall Street estimate on the top line but beating the estimate on the bottom line.

The San Francisco-based genetic testing firm posted revenues of $10.3 million for the three-month period ended March 31, 2017, compared with $4 million for the first quarter of 2016. Despite the strong growth, the firm still fell shy of analysts' consensus estimate of $10.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.